WHO ICTRP trial
Protective effect of Shenyuan Yiqi Huoxue capsule (SYD) on patients with…
ChiCTR-TRC-13003707 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TRC-13003707 |
|---|---|
| Public title | Protective effect of Shenyuan Yiqi Huoxue capsule (SYD) on patients with unstable angina undergoing elective PCI: Randomized, double-blind, placebo-controlled trial |
| Scientific title | Protective effect of Shenyuan Yiqi Huoxue capsule (SYD) on patients with unstable angina undergoing elective PCI: Randomized, double-blind, placebo-controlled trial |
| Primary sponsor | Beijing Traditional Chinese Medicine Hospital affiliated of Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Other |
| Countries | China |
| Conditions | Unstable angina |
| Interventions | 2:Shenyuan Yiqi Huoxue capsule;1:Aspirin 100mg/d; clopidogrel 75mg/d; Isosorbide mononitrate tablets 20mg b.i.d; Lipitor 1 time/night |
| Registration date | Oct 19, 2013 |
| Target size | 2:30;1:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: